Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Hair loss treatment caused more hair loss in a man.

A rare case shows alopecia areata and ITP occurring together, needing more research.

A woman developed facial hair cysts after using a 3% minoxidil solution for hair loss, which disappeared after stopping the treatment and removing the cysts surgically.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Microneedling with 5% minoxidil improves hair loss in Chinese men by activating Wnt/ß-catenin pathway.

Micrografts are a safe and effective treatment for hair loss in both men and women.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Certain genes are linked to the risk of developing Alopecia Areata.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

New research is helping develop better treatments for alopecia areata.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.